Seattle company plays key part in creating breakthrough tuberculosis treatment


A new drug developed has been granted Food and Drug Administration approval — offering hope to patients with drug-resistant tuberculosis.

Previous Inc. 5000: Sacramento region has 27 companies on this year's list
Next Methodist invests in new tech for area's many stroke patients